GR-DD101

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGR-DD101
Drug Alias NameGR-DD101
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionMetastasis inhibitorsBone resorption inhibitors
TargetsUpdating
Therapy Area/IndicationsBone metastases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPhaxiam Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhaxiam Therapeutics SA
Active IndicationsN/A
Inactive IndicationsBone metastases

Other Information

ATC CodeN/A
Related LinksN/A